tiprankstipranks
Trending News
More News >
Zai Lab (ZLAB)
NASDAQ:ZLAB
US Market
Advertisement

Zai Lab (ZLAB) Stock Forecast & Price Target

Compare
672 Followers
See the Price Targets and Ratings of:

ZLAB Analyst Ratings

Strong Buy
6Ratings
Strong Buy
5 Buy
1 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Zai
Lab
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZLAB Stock 12 Month Forecast

Average Price Target

$58.04
▲(72.89%Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Zai Lab in the last 3 months. The average price target is $58.04 with a high forecast of $75.00 and a low forecast of $38.20. The average price target represents a 72.89% change from the last price of $33.57.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","31":"$31","46":"$46","61":"$61","76":"$76"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$75.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":58.04,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$58.04</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$38.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,31,46,61,76],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.17,38.23384615384616,41.29769230769231,44.361538461538466,47.425384615384615,50.48923076923077,53.55307692307693,56.61692307692308,59.68076923076923,62.744615384615386,65.80846153846154,68.87230769230769,71.93615384615384,{"y":75,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.17,36.92923076923077,38.68846153846154,40.44769230769231,42.206923076923076,43.966153846153844,45.72538461538461,47.48461538461538,49.24384615384615,51.00307692307692,52.76230769230769,54.521538461538455,56.28076923076923,{"y":58.04,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.17,35.403076923076924,35.636153846153846,35.86923076923077,36.1023076923077,36.33538461538462,36.56846153846154,36.80153846153846,37.034615384615385,37.26769230769231,37.50076923076924,37.73384615384616,37.96692307692308,{"y":38.2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.78,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.29,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.44,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.94,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.86,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.46,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.19,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.19,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.64,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.29,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.15,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.19,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.17,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$75.00Average Price Target$58.04Lowest Price Target$38.20
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ZLAB
TipRanks AITipRanks
Not Ranked
TipRanks
$34
Hold
1.28%
Upside
Reiterated
07/19/25
Zai Lab's overall score is driven by robust revenue growth and a positive earnings outlook, tempered by significant profitability and cash flow challenges. The approval of key corporate proposals adds governance strength, but valuation concerns remain due to its negative earnings and lack of dividends.
Scotiabank Analyst forecast on ZLAB
Louise ChenScotiabank
Scotiabank
$55
Buy
63.84%
Upside
Reiterated
07/02/25
Scotiabank Keeps Their Buy Rating on Zai Lab (ZLAB)
Leerink Partners Analyst forecast on ZLAB
Jonathan ChangLeerink Partners
Leerink Partners
$73$75
Buy
123.41%
Upside
Reiterated
07/01/25
Zai Lab (ZLAB) Receives a Buy from Leerink Partners
Citi
$66
Buy
96.60%
Upside
Assigned
06/30/25
Zai Lab's Promising Phase 3 Trial Results and Future Potential Justify Buy Rating
J.P. Morgan Analyst forecast on ZLAB
Anupam RamaJ.P. Morgan
J.P. Morgan
Buy
Reiterated
06/30/25
Zai Lab's Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating
Bank of America Securities Analyst forecast on ZLAB
David LiBank of America Securities
Bank of America Securities
$38.2
Hold
13.79%
Upside
Reiterated
06/18/25
Analysts Offer Insights on Healthcare Companies: Zai Lab (NASDAQ: ZLAB), LifeMD (NASDAQ: LFMD) and Novo Nordisk (NYSE: NVO)
Cantor Fitzgerald Analyst forecast on ZLAB
Li WatsekCantor Fitzgerald
Cantor Fitzgerald
$56
Buy
66.82%
Upside
Reiterated
06/02/25
Cantor Fitzgerald Sticks to Its Buy Rating for Zai Lab (ZLAB)
Jefferies Analyst forecast on ZLAB
Michael YeeJefferies
Jefferies
$50
Buy
48.94%
Upside
Reiterated
04/09/25
Zai Lab's Resilience and Promising Pipeline Justify Buy Rating Amid Geopolitical Challenges
Morgan Stanley Analyst forecast on ZLAB
Jack LinMorgan Stanley
Morgan Stanley
$50
Buy
48.94%
Upside
Reiterated
09/27/24
Morgan Stanley on Zai Lab (ZLAB) Post BMY (BMY) Approval: We believe it should bode moderately positively for ZLAB sharesMorgan Stanley analyst Jack Lin reiterated an Overweight rating and $50.00 price target on Zai Lab (NASDAQ: ZLAB).
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ZLAB
TipRanks AITipRanks
Not Ranked
TipRanks
$34
Hold
1.28%
Upside
Reiterated
07/19/25
Zai Lab's overall score is driven by robust revenue growth and a positive earnings outlook, tempered by significant profitability and cash flow challenges. The approval of key corporate proposals adds governance strength, but valuation concerns remain due to its negative earnings and lack of dividends.
Scotiabank Analyst forecast on ZLAB
Louise ChenScotiabank
Scotiabank
$55
Buy
63.84%
Upside
Reiterated
07/02/25
Scotiabank Keeps Their Buy Rating on Zai Lab (ZLAB)
Leerink Partners Analyst forecast on ZLAB
Jonathan ChangLeerink Partners
Leerink Partners
$73$75
Buy
123.41%
Upside
Reiterated
07/01/25
Zai Lab (ZLAB) Receives a Buy from Leerink Partners
Citi
$66
Buy
96.60%
Upside
Assigned
06/30/25
Zai Lab's Promising Phase 3 Trial Results and Future Potential Justify Buy Rating
J.P. Morgan Analyst forecast on ZLAB
Anupam RamaJ.P. Morgan
J.P. Morgan
Buy
Reiterated
06/30/25
Zai Lab's Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating
Bank of America Securities Analyst forecast on ZLAB
David LiBank of America Securities
Bank of America Securities
$38.2
Hold
13.79%
Upside
Reiterated
06/18/25
Analysts Offer Insights on Healthcare Companies: Zai Lab (NASDAQ: ZLAB), LifeMD (NASDAQ: LFMD) and Novo Nordisk (NYSE: NVO)
Cantor Fitzgerald Analyst forecast on ZLAB
Li WatsekCantor Fitzgerald
Cantor Fitzgerald
$56
Buy
66.82%
Upside
Reiterated
06/02/25
Cantor Fitzgerald Sticks to Its Buy Rating for Zai Lab (ZLAB)
Jefferies Analyst forecast on ZLAB
Michael YeeJefferies
Jefferies
$50
Buy
48.94%
Upside
Reiterated
04/09/25
Zai Lab's Resilience and Promising Pipeline Justify Buy Rating Amid Geopolitical Challenges
Morgan Stanley Analyst forecast on ZLAB
Jack LinMorgan Stanley
Morgan Stanley
$50
Buy
48.94%
Upside
Reiterated
09/27/24
Morgan Stanley on Zai Lab (ZLAB) Post BMY (BMY) Approval: We believe it should bode moderately positively for ZLAB sharesMorgan Stanley analyst Jack Lin reiterated an Overweight rating and $50.00 price target on Zai Lab (NASDAQ: ZLAB).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zai Lab

1 Month
xxx
Success Rate
8/15 ratings generated profit
53%
Average Return
+5.30%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.33% of your transactions generating a profit, with an average return of +5.30% per trade.
3 Months
xxx
Success Rate
16/37 ratings generated profit
43%
Average Return
-1.26%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 43.24% of your transactions generating a profit, with an average return of -1.26% per trade.
1 Year
Anupam RamaJ.P. Morgan
Success Rate
8/14 ratings generated profit
57%
Average Return
+11.99%
reiterated a buy rating 21 days ago
Copying Anupam Rama's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +11.99% per trade.
2 Years
xxx
Success Rate
8/14 ratings generated profit
57%
Average Return
+8.32%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +8.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZLAB Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
3
7
10
13
11
Buy
6
3
4
4
3
Hold
2
3
7
11
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
13
21
28
25
In the current month, ZLAB has received 14 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. ZLAB average Analyst price target in the past 3 months is 58.04.
Each month's total comprises the sum of three months' worth of ratings.

ZLAB Financial Forecast

ZLAB Earnings Forecast

Next quarter’s earnings estimate for ZLAB is -$0.41 with a range of -$0.56 to -$0.35. The previous quarter’s EPS was -$0.04. ZLAB beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.43% of the time in the same period. In the last calendar year ZLAB has Preformed in-line its overall industry.
Next quarter’s earnings estimate for ZLAB is -$0.41 with a range of -$0.56 to -$0.35. The previous quarter’s EPS was -$0.04. ZLAB beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.43% of the time in the same period. In the last calendar year ZLAB has Preformed in-line its overall industry.

ZLAB Sales Forecast

Next quarter’s sales forecast for ZLAB is $124.95M with a range of $113.75M to $132.31M. The previous quarter’s sales results were $106.49M. ZLAB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.77% of the time in the same period. In the last calendar year ZLAB has Preformed in-line its overall industry.
Next quarter’s sales forecast for ZLAB is $124.95M with a range of $113.75M to $132.31M. The previous quarter’s sales results were $106.49M. ZLAB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.77% of the time in the same period. In the last calendar year ZLAB has Preformed in-line its overall industry.

ZLAB Stock Forecast FAQ

What is ZLAB’s average 12-month price target, according to analysts?
Based on analyst ratings, Zai Lab’s 12-month average price target is 58.04.
    What is ZLAB’s upside potential, based on the analysts’ average price target?
    Zai Lab has 72.89% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ZLAB a Buy, Sell or Hold?
          Zai Lab has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Zai Lab’s price target?
            The average price target for Zai Lab is 58.04. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $75.00 ,the lowest forecast is $38.20. The average price target represents 72.89% Increase from the current price of $33.57.
              What do analysts say about Zai Lab?
              Zai Lab’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of ZLAB?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis